Stock Price Targets and Analyst Ratings

Stay on top of the latest U.S. and international stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view the companies you follow. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

On This Page:About Stock Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AADX Applied Aerospace & Defense	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Epstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.69 +0.8%	$24.00	Buy
AADX Applied Aerospace & Defense	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.69 +0.8%	$23.00	Outperform
AADX Applied Aerospace & Defense	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Siegmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.69 +0.8%	$24.00	Buy
AADX Applied Aerospace & Defense	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristine Liwag Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.69 +0.8%	$23.00	Equal Weight
AADX Applied Aerospace & Defense	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Arment Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.69 +0.8%	$30.00	Outperform
ABNB Airbnb	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Sebastian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.17 +1.1%	$150.00 ➝ $160.00	Outperform
AC Air Canada	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$24.49 -0.7%	C$22.00 ➝ C$28.00	Outperform
ACAD ACADIA Pharmaceuticals	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sumant Kulkarni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.20 -0.5%	$32.00 ➝ $36.00	Buy
ACAD ACADIA Pharmaceuticals	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.20 -0.5%	$32.00 ➝ $35.00	Buy
ACAD ACADIA Pharmaceuticals	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.20 -0.5%	$37.00	Buy
Solar is dead. Here’s what replaces it. (Ad) Starting July 4th, every new solar and wind project in America loses its federal tax credits. But one zero-carbon energy source retains full government backing for eight more years - and it runs around the clock without batteries. Investment in this sector has surged 100x in seven years. The Pentagon named it a top energy priority, California mandated it, and Google, Meta, and Berkshire Hathaway are already under contract. One company controls the entire chain from the ground to the grid. See the last clean energy source with full government backing
ACI Albertsons Companies	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.46 -0.9%	$22.00 ➝ $17.00	Buy
ACI Albertsons Companies	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.46 -0.9%	$21.00 ➝ $18.00	Overweight
ADI Analog Devices	Target Set by	Fundamental Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$391.78 +1.3%	$550.00
ADI Analog Devices	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$391.78 +1.3%	$510.00 ➝ $550.00	Overweight
ADPT Adaptive Biotechnologies	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.40 +2.1%	$21.00 ➝ $22.00	Buy
AEIS Advanced Energy Industries	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.15 +0.0%	$400.00 ➝ $450.00	Overweight
AEIS Advanced Energy Industries	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.15 +0.0%	$400.00 ➝ $450.00	Overweight
AFRM Affirm	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.79 +2.9%		Underweight ➝ Overweight
AKZOY Akzo Nobel	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.58 -1.0%		Hold
ALAB Astera Labs	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Natalia Winkler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$455.96 +16.4%	$205.00 ➝ $400.00	Neutral
ALGM Allegro MicroSystems	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.37 +14.6%	$54.00 ➝ $67.00	Outperform
ALKS Alkermes	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Burnett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.53 -4.6%	$44.00 ➝ $65.00	Overweight
ALKS Alkermes	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.53 -4.6%		Neutral ➝ Underperform
ALNY Alnylam Pharmaceuticals	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$293.52 +0.7%	$510.00 ➝ $470.00	Buy
AMAT Applied Materials	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Barger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$694.64 +10.8%	$550.00 ➝ $750.00	Overweight
AMAT Applied Materials	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$694.64 +10.8%	$650.00 ➝ $850.00	Overweight
AMAT Applied Materials	Target Set by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$694.64 +10.8%	$850.00
AMD Advanced Micro Devices	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$539.49 +3.4%	$500.00 ➝ $700.00	Overweight
AMPH Amphastar Pharmaceuticals	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.71 -4.9%	$25.00 ➝ $20.00	Neutral ➝ Underperform
APP AppLovin	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Marok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$498.76 +4.5%	$640.00	Strong-Buy
AR Antero Resources	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.45 -2.1%	$56.00 ➝ $48.00	Overweight
ARE Aecon Group	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$44.61 +1.2%	C$56.00 ➝ C$57.00	Buy
ARMK Aramark	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ian Zaffino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.21 +0.3%	$60.00 ➝ $65.00	Outperform
ARMK Aramark	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.21 +0.3%	$65.00	Buy
ASLE AerSale	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.33 -3.4%	$7.50	Neutral
ASML ASML	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,883.11 +4.9%		Buy
ATZ Aritzia	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$153.63 -2.9%	C$171.00 ➝ C$175.00	Outperform
AUB Atlantic Union Bankshares	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.18 +0.8%	$42.00 ➝ $45.00	Equal Weight
AXP American Express	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$340.86 +0.1%		Neutral ➝ Overweight
BAC Bank of America	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.94 +0.1%	$61.00 ➝ $67.00	Overweight
An event four years in the making (Ad) Jeff Brown, Founder and CEO of Brownstone Research, says July 23 marks a pivotal turning point for biotech - one he has been tracking for four years. He's calling it 'The Biotech Moment': three converging market forces he believes could fuel the sector's biggest gains yet. Small biotech stocks are already posting moves of 256%, 453%, and 850% in a matter of hours. Brown has built an AI trading system designed to identify these fast-movers before they surge, and he's sharing three small biotech plays at his free July 1 briefing. Register free and get three biotech buy signals just for attending. Reserve your free spot at The Biotech Moment briefing now
BBD.B Bombardier, Inc. Class B	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$330.00 +1.4%	C$332.00 ➝ C$383.00	Outperform
BGEO Lion Finance Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GEL 11,110.00 +2.1%	£131 ➝ £139	Overweight
BHVN Biohaven	Target Set by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.99 -5.3%	$11.00
BHVN Biohaven	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.99 -5.3%	$12.00 ➝ $11.00	Neutral ➝ Underperform
BIIB Biogen	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.63 +0.3%	$255.00 ➝ $256.00	Buy
BIOVF Swedish Orphan Biovitrum	Downgraded by	Pareto Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$48.00		Hold
BLD TopBuild	Target Set by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$358.54 -15.7%	$360.00
BLLN Billiontoone	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.40 +1.9%	$120.00 ➝ $125.00	Buy
BRKR Bruker	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.71 -2.0%	$50.00 ➝ $70.00	Buy
BRSL Brightstar Lottery	Downgraded by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Staszak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.92 -2.5%		Buy ➝ Hold
C Citigroup	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$142.61 +0.6%	$154.00 ➝ $164.00	Overweight
CASY Casey's General Stores	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kelly Bania Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$780.24 +0.2%	$950.00	Market Perform ➝ Outperform
CBC Central Bancompany	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.44 +1.9%	$29.00 ➝ $32.00	Overweight
CBSH Commerce Bancshares	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.09 +0.5%	$61.00 ➝ $65.00	Positive
CCJ Cameco	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew D. Wong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.55 -0.9%	$160.00 ➝ $175.00	Outperform
CCO Cameco	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$146.92 -0.7%	C$160.00 ➝ C$175.00	Outperform
CER Cerillion	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,100	GBX 2,060 ➝ GBX 2,060	Buy
CFG Citizens Financial Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.41 +0.0%	$73.00 ➝ $79.00	Overweight
CFR Cullen/Frost Bankers	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$154.50 -0.5%	$133.00 ➝ $141.00	Underweight
CGY Calian Group	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$85.51 +0.6%	C$103.00 ➝ C$105.00	Buy
CHRD Chord Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$115.97 -0.5%	$175.00 ➝ $169.00	Overweight
CHRD Chord Energy	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$115.97 -0.5%		Outperform
CHTR Charter Communications	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$146.17 +9.4%	$230.00 ➝ $190.00	Buy
CMC Commercial Metals	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Katja Jancic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.78 -6.4%	$80.00 ➝ $77.00	Market Perform
CMCSA Comcast	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.19 +4.4%	$35.50 ➝ $32.00	Buy
CNMD CONMED	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Travis Steed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.51 -4.0%	$40.00	Neutral ➝ Underperform
CNQ Canadian Natural Resources	Upgraded by	Gerdes Energy Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$55.89 -0.2%	C$67.00 ➝ C$69.00	Neutral ➝ Buy
CNX CNX Resources	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.29 -1.3%	$34.00 ➝ $32.00	Underweight
COF Capital One Financial	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$202.07 -0.9%		Neutral ➝ Overweight
CREO Creo Medical Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 14.63 +7.1%	GBX 40 ➝ GBX 40	House Stock
CRK Comstock Resources	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.22 -0.6%	$18.00 ➝ $16.00	Equal Weight
CRM Salesforce	Downgraded by	Phillip Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$158.12 -0.2%	$253.00 ➝ $166.00	Buy ➝ Neutral
CTAS Cintas	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$169.08 -1.6%	$215.00 ➝ $200.00	Neutral
CTO CTO Realty Growth	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.92 +0.8%	$25.00	Strong-Buy
CUBI Customers Bancorp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.17 -2.3%	$83.00 ➝ $88.00	Equal Weight
CVE Cenovus Energy	Upgraded by	Gerdes Energy Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$35.54 +1.1%	C$42.00 ➝ C$46.00	Neutral ➝ Buy
CVI CVR Energy	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$28.27 +4.3%	$35.00	Neutral
CVX Chevron	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$168.61 -1.4%	$214.00 ➝ $210.00	Overweight
CYTK Cytokinetics	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashwani Verma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.26 +6.2%	$69.00 ➝ $115.00	Neutral ➝ Buy
DANOY Danone	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.55 +0.5%		Overweight
DH Definitive Healthcare	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allen Lutz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.72 +8.8%	$0.70	Buy ➝ Underperform
DHT.UN DRI Healthcare Trust	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$18.51 +6.1%	C$22.50 ➝ C$23.50	Strong-Buy
DINO HF Sinclair	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.84 +3.7%	$80.00 ➝ $79.00	Hold
DK Delek US	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.57 +7.8%	$50.00 ➝ $58.00	Hold ➝ Buy
DOCS Doximity	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.53 -1.7%		Underperform
DOCS Doximity	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allen Lutz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.53 -1.7%	$38.00 ➝ $20.00	Buy ➝ Underperform
DOX Amdocs	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin Au Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.45 -1.0%		Sector Weight
DUOL Duolingo	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wyatt Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.03 -4.5%	$120.00	Neutral
EIF Exchange Income	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$130.52 -0.2%	C$127.00 ➝ C$150.00	Outperform
ELAN Elanco Animal Health	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.76 +0.8%		Overweight
The wait is finally over (Ad) Biotech analyst Jeff Brown is going on record: a rare convergence of three forces is set to hit by July 23, triggering what he calls the next golden age of biotech. In the past 40 years, this has happened only three times - and each time, small plays doubled and tripled in days. Already, early movers are posting gains of 292% in 9 days and 526% in 3 months. Brown is hosting a free briefing - The Biotech Moment - on Wednesday, July 1, at 8 p.m. ET, including details on three small biotech plays he believes could launch soon. Register free for The Biotech Moment briefing on July 1
ELVN Enliven Therapeutics	Target Raised by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boris Peaker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.85 +1.5%	$45.00 ➝ $70.00	Buy
EQIX Equinix	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,085.17 -0.6%	$1,240.00 ➝ $1,260.00	Buy
EQNR Equinor ASA	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.14 +0.4%	$42.00 ➝ $37.00	Hold
EQPT EquipmentShare.com	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Weber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.23 -1.2%	$22.00	Neutral
EQX Equinox Gold	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$13.82 +0.1%	C$23.00 ➝ C$20.00	Buy
EVMN Evommune	Downgraded by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Phipps Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.08 -40.1%		Outperform ➝ Market Perform
EWBC East West Bancorp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.09 -0.3%	$128.00 ➝ $131.00	Equal Weight
EXE Expand Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.54 -1.1%	$139.00 ➝ $131.00	Overweight
FANG Diamondback Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$180.54 +0.4%	$229.00 ➝ $216.00	Overweight
FC Firm Capital Mortgage Investment	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$12.23 +0.8%	C$12.00	Outperform
FCEL FuelCell Energy	Upgraded by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Souther Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.80 +24.2%	$13.00 ➝ $32.00	Neutral ➝ Buy
FITB Fifth Third Bancorp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.89 +1.0%	$60.00 ➝ $64.00	Overweight
FLG Flagstar Bank, National Association	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.92 -2.3%	$14.00 ➝ $15.00	Equal Weight
FLTR Flutter Entertainment	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 7,840.16 +8.3%	£680 ➝ £700	Sell
FLUT Flutter Entertainment	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Monique Pollard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.45 +0.3%		Sell
FRT Federal Realty Investment Trust	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$125.33 +0.2%	$135.00	Outperform
FRT Federal Realty Investment Trust	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$125.33 +0.2%	$128.00 ➝ $131.00	Buy
FSG Foresight Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 431 +5.1%	GBX 560 ➝ GBX 560	Buy
FUN Six Flags Entertainment	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.49 -6.9%		Neutral ➝ Outperform
FUN Six Flags Entertainment	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.49 -6.9%	$29.00	Market Outperform
FVA ForViva	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 132 -1.7%	GBX 190 ➝ GBX 190	Buy
GH Guardant Health	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$153.74 +3.0%	$135.00 ➝ $160.00	Buy
GNRC Generac	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christine Cho Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$282.71 +1.5%	$228.00 ➝ $285.00	Equal Weight
GPK Graphic Packaging	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Detlef Winckelmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.64 -3.4%	$11.70	Neutral
GS The Goldman Sachs Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,022.03 +0.2%	$1,021.00 ➝ $1,099.00	Equal Weight
GS The Goldman Sachs Group	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,022.03 +0.2%	$972.00 ➝ $1,070.00	Market Perform
GTLB GitLab	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.85 +2.7%		Outperform
HBAN Huntington Bancshares	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.82 +0.2%	$20.00 ➝ $21.00	Overweight
HD Home Depot	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Forbes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$350.54 +0.5%		Buy
HLLY Holley	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian McNamara Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.59 +2.2%	$7.00	Buy
HOOD Robinhood Markets	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$101.83 +3.2%	$108.00 ➝ $121.00	Buy
HP Helmerich & Payne	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.40 -1.2%	$38.00 ➝ $36.00	Neutral
HRI Herc	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Weber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$145.67 -3.7%	$160.00	Neutral
IES Invinity Energy Systems	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 29.10 -1.4%	GBX 50 ➝ GBX 50	Buy
ILMN Illumina	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$181.10 +2.6%	$180.00 ➝ $200.00	Buy
INIO Innio	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicole Deblase Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$41.00	Hold
INIO Innio	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Ritchie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$42.00	Buy
INIO Innio	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Amit Mehrotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$47.00	Buy
INIO Innio	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Kaplowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$42.00	Neutral
INIO Innio	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Kallo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$50.00	Outperform
INIO Innio	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Dendrinos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$39.00	Sector Perform
INIO Innio	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Arcaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$47.00	Overweight
INIO Innio	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Obin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$46.00	Buy
INIO Innio	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Moses Sutton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$48.00	Outperform
INIO Innio	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Strouse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.32 +2.8%	$44.00	Overweight
INTC Intel	Target Set by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$131.72 +2.6%	$150.00
INTC Intel	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.72 +2.6%	$90.00 ➝ $150.00	Neutral
IRDM Iridium Communications	Downgraded by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.59 +25.4%		Outperform ➝ Market Perform
ITRG Integra Resources	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Reagor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.22 -4.7%	$6.00	Buy
IVT InvenTrust Properties	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Schmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.21 +0.1%	$37.00 ➝ $38.00	Buy
The BNZI Story Is Evolving with a Zack’s BUY! (Ad) Banzai International (NASDAQ: BNZI) just earned a Zacks Rank No. 2 (Buy) upgrade, reflecting growing confidence in its earnings outlook. The company maintains gross margins above 80%, has reduced debt, and grown its customer base to more than 150,000 users. Recent catalysts include a strategic alliance with Ingram Micro, a proposed ConnectAndSell acquisition, and a $5.5 million annualized cost reduction initiative - all aimed at building a more scalable AI-powered sales and marketing platform. Add BNZI to your watchlist and explore the full growth story today
JBS JBS	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucas Ferreira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.23 +0.0%	$18.50 ➝ $18.00	Overweight
JKHY Jack Henry & Associates	Target Set by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$136.73 +1.3%	$165.00
JPM JPMorgan Chase & Co.	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$329.85 +0.2%	$336.00 ➝ $362.00	Equal Weight
KELYA Kelly Services	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Steinke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.85 +0.9%		Outperform
KEY KeyCorp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.16 -0.5%	$24.00 ➝ $25.00	Equal Weight
KEY KeyCorp	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.16 -0.5%		Positive
KGH Knights Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 178 -0.3%	GBX 355 ➝ GBX 355	Buy
KIM Kimco Realty	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.82 -0.3%	$29.00	Strong-Buy
KLAC KLA	Target Set by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$278.39 +12.0%	$250.00 ➝ $325.00	Overweight
KNSA Kiniksa Pharmaceuticals International	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.41 +5.4%	$59.00 ➝ $72.00	Outperform
KYMR Kymera Therapeutics	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srikripa Devarakonda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.32 +1.1%	$116.00 ➝ $136.00	Buy
KYMR Kymera Therapeutics	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kalpit Patel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.32 +1.1%	$117.00 ➝ $155.00	Buy
LEVI Levi Strauss & Co.	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.42 -0.5%	$23.00 ➝ $25.00	Neutral
LFTO Liftoff Mobile	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Cost Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$30.00	Equal Weight
LFTO Liftoff Mobile	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$35.00	Outperform
LFTO Liftoff Mobile	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ralph Schackart Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%		Outperform
LFTO Liftoff Mobile	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Ju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$38.00	Buy
LFTO Liftoff Mobile	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Lampen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$35.00	Buy
LFTO Liftoff Mobile	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alec Brondolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$32.00	Overweight
LFTO Liftoff Mobile	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Heaney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$34.00	Buy
LFTO Liftoff Mobile	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Sandler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$34.00	Overweight
LFTO Liftoff Mobile	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Sheridan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$40.00	Buy
LFTO Liftoff Mobile	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Black Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$37.00	Buy
LFTO Liftoff Mobile	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Deepak Mathivanan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$33.00	Overweight
LFTO Liftoff Mobile	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Marok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$32.00	Outperform
LFTO Liftoff Mobile	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bernie McTernan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.47 -7.0%	$42.00	Buy
LFTO Liftoff Mobile	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.47 -7.0%		Peer Perform
LIND Lindblad Expeditions	Target Set by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$28.35 -4.1%	$31.00
LIND Lindblad Expeditions	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Albanese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.35 -4.1%	$25.00 ➝ $34.00	Buy
LNTH Lantheus	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Turkaly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.58 -0.2%	$115.00	Market Outperform
LQDA Liquidia	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$75.12 -3.9%	$64.00 ➝ $79.00	Buy ➝ Neutral
LRCX Lam Research	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$410.91 +8.4%	$500.00
LRCX Lam Research	Target Set by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$410.91 +8.4%	$425.00 ➝ $500.00	Overweight
LTH Life Time Group	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Randal Konik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.23 +0.5%	$41.00 ➝ $51.00	Buy
LUCK Lucky Strike Entertainment	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.83 -0.8%		Market Perform
LUCK Lucky Strike Entertainment	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.83 -0.8%		Market Perform
MA Mastercard	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$510.64 +2.3%		Overweight
MBIN Merchants Bancorp	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.36 +0.7%	$46.00 ➝ $49.00	Positive
MCD McDonald's	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Carril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$267.60 -0.8%	$330.00 ➝ $315.00	Overweight
MEI Methode Electronics	Upgraded by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Prestopino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.37 +1.1%	$25.00	Market Perform ➝ Outperform
MGY Magnolia Oil & Gas	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Rezvan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.74 -3.9%		Overweight
MICC Magnum Ice Cream	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.55 +0.3%		Overweight
MKP MCAN Mortgage	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$25.69 +3.9%	C$27.00	Outperform
MKSI MKS	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Barger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$416.00 +7.0%	$360.00 ➝ $475.00	Overweight
MKSI MKS	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$416.00 +7.0%	$400.00 ➝ $600.00	Overweight
MLM Martin Marietta Materials	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$578.71 -6.1%		Outperform
MMM 3M	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$162.58 -0.9%	$170.00 ➝ $175.00	Hold
MNPR Monopar Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.56 +7.8%	$105.00	Buy
MNPR Monopar Therapeutics	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$94.56 +7.8%	$105.00
MPC Marathon Petroleum	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$259.35 +2.1%	$320.00 ➝ $315.00	Buy
An event four years in the making (Ad) Jeff Brown, Founder and CEO of Brownstone Research, says July 23 marks a pivotal turning point for biotech - one he has been tracking for four years. He's calling it 'The Biotech Moment': three converging market forces he believes could fuel the sector's biggest gains yet. Small biotech stocks are already posting moves of 256%, 453%, and 850% in a matter of hours. Brown has built an AI trading system designed to identify these fast-movers before they surge, and he's sharing three small biotech plays at his free July 1 briefing. Register free and get three biotech buy signals just for attending. Reserve your free spot at The Biotech Moment briefing now
MRVL Marvell Technology	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$277.75 +4.1%	$220.00 ➝ $300.00	Neutral
MRVL Marvell Technology	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$277.75 +4.1%	$230.00 ➝ $340.00	Buy
MS Morgan Stanley	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$212.17 +0.1%	$220.00 ➝ $240.00	Outperform
MTB M&T Bank	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$238.87 +0.7%	$245.00 ➝ $253.00	Equal Weight
MTB M&T Bank	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$238.87 +0.7%		Positive
MTDR Matador Resources	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.80 -0.2%	$75.00 ➝ $66.00	Equal Weight
MUR Murphy Oil	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.91 -2.0%	$37.00 ➝ $35.00	Underweight
MXL MaxLinear	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.47 +12.3%	$105.00 ➝ $110.00	Buy
NKE NIKE	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.46 +1.7%	$52.00 ➝ $47.00	Neutral
NMRK Newmark Group	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.26 -0.1%	$19.00	Overweight
NOG Northern Oil and Gas	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.82 -7.1%	$29.00 ➝ $25.00	Underweight
NOW ServiceNow	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.90 +1.6%	$150.00	Buy
NOW ServiceNow	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Weed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.90 +1.6%		Outperform
NRIX Nurix Therapeutics	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.85 +4.1%	$28.00	Outperform
NTRA Natera	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$272.31 +4.0%	$270.00 ➝ $290.00	Buy
NTRS Northern Trust	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$174.91 +0.6%	$157.00 ➝ $170.00	Underweight
NVDA NVIDIA	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$194.97 +1.3%		Buy
NXPI NXP Semiconductors	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$278.37 +0.5%	$380.00 ➝ $400.00	Overweight
OKTA Okta	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.31 +5.7%	$105.00 ➝ $135.00	Sector Perform
OLLI Ollie's Bargain Outlet	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.33 +0.6%	$129.00 ➝ $112.00	Buy
OMG Omai Gold Mines	Target Set by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$2.21 -1.8%	C$4.50	Outperformer
ON onsemi	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.57 -2.3%	$100.00 ➝ $110.00	Neutral
ON onsemi	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$88.57 -2.3%		Neutral
ONTO Onto Innovation	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$350.73 +8.3%	$350.00 ➝ $410.00	Overweight
OVV Ovintiv	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.24 +0.1%	$68.00 ➝ $65.00	Equal Weight
OZK Bank OZK	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.63 -0.9%	$54.00 ➝ $56.00	Equal Weight
PANW Palo Alto Networks	Target Raised by	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$332.00 +9.1%	$185.00 ➝ $433.00	Buy
PATH UiPath	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Radi Sultan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.67 +1.3%	$13.00 ➝ $12.00	Neutral
PB Prosperity Bancshares	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.48 -1.2%	$83.00 ➝ $85.00	Overweight
PBF PBF Energy	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.53 +7.9%	$36.00 ➝ $39.00	Sell ➝ Hold
PCTY Paylocity	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry Tillman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.73 -0.6%	$180.00 ➝ $165.00	Buy
PEB Pebblebrook Hotel Trust	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Miller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.32 +1.4%	$17.00 ➝ $22.00	Buy
PFGC Performance Food Group	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.34 +1.7%	$115.00 ➝ $125.00	Buy
PG Procter & Gamble	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$148.40 -0.4%	$169.00 ➝ $170.00	Outperform
PGR Progressive	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Elyse Greenspan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$219.13 -2.3%	$205.00	Equal Weight ➝ Underweight
PLAY Dave & Buster's Entertainment	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.33 -4.1%		Market Perform
PLAY Dave & Buster's Entertainment	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.33 -4.1%		Market Perform
PLD Prologis	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$139.09 -0.6%	$162.00 ➝ $158.00	Outperform
PLTR Palantir Technologies	Upgraded by	President Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$115.67 +2.4%	$25.50 ➝ $133.00	Neutral ➝ Buy
PNC The PNC Financial Services Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.89 +0.8%	$267.00 ➝ $278.00	Equal Weight
PR Permian Resources	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.50 -1.2%	$25.00 ➝ $24.00	Overweight
PRAX Praxis Precision Medicines	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$350.56 +6.9%	$537.00 ➝ $575.00	Buy
PRIM Primoris Services	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Strouse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.22 +4.4%	$105.00 ➝ $116.00	Neutral ➝ Overweight
PRKS United Parks & Resorts	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.72 -0.8%		Market Perform
PRKS United Parks & Resorts	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$46.72 -0.8%		Neutral ➝ Market Perform
PRME Prime Medicine	Upgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arthur He Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.72 +8.5%	$8.00	Neutral ➝ Buy
PRME Prime Medicine	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.72 +8.5%	$8.00
PSX Phillips 66	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$174.17 +1.5%	$213.00 ➝ $220.00	Buy
PTEN Patterson-UTI Energy	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.55 -0.4%	$11.00 ➝ $10.50	Neutral
PTRN Pattern Group	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.45 +6.8%	$27.00	Buy
PYPL PayPal	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.38 +0.2%	$40.00 ➝ $41.00	Sell
PYPL PayPal	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.38 +0.2%		Neutral
QBCRF Quebecor	Reiterated by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$48.32		Buy
QBR.B Quebecor	Target Raised by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$67.81 +2.3%	C$69.00 ➝ C$78.00	Buy
QCOM Qualcomm	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$188.72 -0.4%	$170.00 ➝ $210.00	Neutral
QDEL QuidelOrtho	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tycho Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.23 +32.2%		Hold
QNT Quantinuum	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Troy Jensen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$90.00	Overweight
QNT Quantinuum	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Garrigan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$90.00	Buy
QNT Quantinuum	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$72.84 -3.6%	$78.00
QNT Quantinuum	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krish Sankar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%		Buy
QNT Quantinuum	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$93.00	Buy
QNT Quantinuum	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$72.84 -3.6%	$98.00	Outperform
QNT Quantinuum	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harlan Sur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$97.00	Overweight
QNT Quantinuum	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$78.00	Equal Weight
QNT Quantinuum	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$100.00	Buy
QNT Quantinuum	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$100.00	Buy
QNT Quantinuum	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John McPeake Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$155.00	Buy
QNT Quantinuum	Initiated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$90.00	Outperform
QNT Quantinuum	Initiated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shannon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.84 -3.6%	$100.00	Buy
QNT Quantinuum	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$72.84 -3.6%	$94.00	Outperform
QUBT Quantum Computing	Target Set by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John McPeake Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.91 +8.0%	$22.00	Buy
QURE uniQure	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.39 -0.3%	$50.00 ➝ $80.00	Buy
RBLX Roblox	Target Set by	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.37 +14.3%	$95.00	Neutral ➝ Buy
RBLX Roblox	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.37 +14.3%		Buy
RBLX Roblox	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bernie McTernan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.37 +14.3%		Buy
RBLX Roblox	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.37 +14.3%		Market Perform
RBLX Roblox	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.37 +14.3%		Outperform
RBLX Roblox	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Sandler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.37 +14.3%		Equal Weight ➝ Outperform
RBLX Roblox	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.37 +14.3%		Overweight
RBLX Roblox	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.37 +14.3%		Buy ➝ Underperform
RBLX Roblox	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Schoell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.37 +14.3%		Neutral ➝ Buy
REG Regency Centers	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.30 -0.6%	$88.00	Outperform
RF Regions Financial	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.26 +0.7%	$34.00 ➝ $35.00	Equal Weight
RKLB Rocket Lab	Reiterated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$97.95 +15.9%	$120.00	Buy
RKT Rocket Companies	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.48 +3.2%		Buy
ROSE Rose Petroleum plc (ROSE.L)	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 324 +0.9%	GBX 450 ➝ GBX 450	Buy
RR Rolls-Royce Holdings plc	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,406.20 -1.8%	GBX 1,500 ➝ GBX 1,625	Overweight
RRC Range Resources	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.34 -3.3%	$50.00 ➝ $44.00	Equal Weight
RVMD Revolution Medicines	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$192.62 +5.8%	$183.00 ➝ $235.00	Buy
RXEEY Rexel	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.92 +1.0%		Overweight
SAV Savannah Resources	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6.30 +3.3%	GBX 13 ➝ GBX 13	Speculative Buy
SBGSY Schneider Electric	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$64.00 +2.5%		Overweight
SDRL Seadrill	Reiterated by	BWS Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hamed Khorsand Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.65 -1.0%	$80.00	Buy
SEDG SolarEdge Technologies	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.36 +7.0%	$36.00	Equal Weight
SEI Solaris Energy Infrastructure	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.82 +2.6%	$97.00	Buy
SEZL Sezzle	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rayna Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$170.70 +0.1%		Outperform ➝ Market Perform
SFNC Simmons First National	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.67 -1.1%	$23.00 ➝ $24.00	Equal Weight
SFNC Simmons First National	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.67 -1.1%		Positive
SFNC Simmons First National	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.67 -1.1%	$24.00
SHAK Shake Shack	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.79 -3.7%	$70.00	Buy
SLP Sylvania Platinum	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 81.50 -1.8%	GBX 174 ➝ GBX 174	Buy
SN Smith & Nephew	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,138.50 -0.7%	GBX 1,350 ➝ GBX 1,350	Sector perform
SNDA Sonida Senior Living	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.63 +1.5%	$45.00 ➝ $48.00	Outperform
SNDK Sandisk	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark C. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2,050.39 -1.9%		Outperform
SNWS Smiths News	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 69.82 +3.3%	GBX 85 ➝ GBX 85	Buy
SNWS Smiths News	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 69.82 +3.3%	GBX 95 ➝ GBX 95	Buy
SOLI Solid State	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 205 +5.1%	GBX 245 ➝ GBX 275	Buy
SPG Simon Property Group	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samir Khanal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.62 +0.3%	$225.00 ➝ $236.00	Buy
SSAAY SSAB	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.70 -0.1%		Overweight
SSMR Sunshine Silver Mining & Refining	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos De Alba Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.42	$23.00	Overweight
SSMR Sunshine Silver Mining & Refining	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.42	$15.00	Sector Perform
SSMR Sunshine Silver Mining & Refining	Initiated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Winmill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.42	$20.00	Sector Outperform
SSMR Sunshine Silver Mining & Refining	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin O'Halloran Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.42	$16.50	Outperform
SSMR Sunshine Silver Mining & Refining	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Hacking Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.42	$18.00	Buy
STB Secure Trust Bank	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,426 +3.9%		House Stock
STGW Stagwell	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.96 -1.1%	$7.25 ➝ $8.00	Buy
STM STMicroelectronics	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$74.63 +4.5%		Underweight ➝ Equal Weight
STT State Street	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$170.34 +1.3%	$166.00 ➝ $183.00	Overweight
STX Seagate Technology	Initiated by	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$968.53 +7.6%	$1,600.00	Buy
STX Seagate Technology	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$968.53 +7.6%	$1,000.00 ➝ $1,300.00	Overweight
STZ Constellation Brands	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$139.89 -4.4%	$185.00 ➝ $170.00	Overweight
SU Suncor Energy	Upgraded by	Gerdes Energy Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$76.43	C$93.00 ➝ C$96.00	Neutral ➝ Buy
SYNA Synaptics	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Seymore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.38 -3.0%	$125.00	Buy ➝ Hold
SYZ Sylogist	Target Lowered by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$3.74 +0.5%	C$6.00 ➝ C$5.50	Outperform
TBPH Theravance Biopharma	Reiterated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Debanjana Chatterjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.06 -3.2%		Buy ➝ Hold
TBPH Theravance Biopharma	Downgraded by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.06 -3.2%		Buy ➝ Neutral
TCOM Trip.com Group	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joyce Ju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.96 -2.3%	$78.00 ➝ $64.00	Buy
TEAM Atlassian	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Weed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.23 +0.6%		Outperform
TER Teradyne	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$463.28 +6.0%	$400.00 ➝ $550.00	Overweight
TNGX Tango Therapeutics	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Newman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.56 +3.5%	$42.00 ➝ $46.00	Buy
TSLA Tesla	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Itay Michaeli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$411.84 +8.5%		Buy
TSLA Tesla	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$411.84 +8.5%		Sell ➝ Neutral
TWST Twist Bioscience	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$98.36 -1.5%	$60.00 ➝ $107.00	Buy
TXN Texas Instruments	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$285.48 +0.0%	$300.00 ➝ $340.00	Neutral
TXN Texas Instruments	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$285.48 +0.0%	$295.00 ➝ $350.00	Buy
U Unity Software	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Marok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.38 +0.5%		Market Perform
UBER Uber Technologies	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$75.32 -1.2%	$100.00
UBS UBS Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.57 +1.0%		Buy
UMBF UMB Financial	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$141.98 -2.0%	$143.00 ➝ $159.00	Overweight
URI United Rentals	Upgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Weber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,122.26 +0.1%	$1,320.00	Neutral ➝ Outperform
USA Americas Silver	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$6.61 -3.5%	C$12.00 ➝ C$11.00	Buy
USB U.S. Bancorp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.32 +0.7%	$64.00 ➝ $67.00	Equal Weight
UTI Universal Technical Institute	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jasper Bibb Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.32 -0.7%	$40.00 ➝ $47.00	Buy
UUGRY United Utilities Group	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.98 +0.9%		Outperform
V Visa	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$341.86 +1.7%		Overweight
VC Visteon	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Itay Michaeli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.94 -7.9%	$130.00 ➝ $135.00	Buy
VCYT Veracyte	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.19 -0.5%	$45.00 ➝ $65.00	Buy
VERX Vertex	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jared Levine Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.40 +0.3%	$14.00	Buy
VLO Valero Energy	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$266.26 +2.7%	$276.00 ➝ $292.00	Hold
VLY Valley National Bancorp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.65 -0.5%	$15.00 ➝ $16.00	Equal Weight
VLY Valley National Bancorp	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.65 -0.5%		Positive
VNOM Viper Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.41 -0.4%	$49.00 ➝ $46.00	Overweight
VOXR Vox Royalty	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Reagor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.77 -3.0%	$8.00	Buy
VRDN Viridian Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Serge Belanger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.79 +5.0%	$32.00	Buy
VRDN Viridian Therapeutics	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derek Archila Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.79 +5.0%	$20.00 ➝ $31.00	Equal Weight ➝ Overweight
VSAT Viasat	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$76.69 +23.8%	$140.00	Outperform
WDC Western Digital	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$651.80 +11.1%	$660.00 ➝ $900.00	Overweight
WDC Western Digital	Target Set by	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$651.80 +11.1%	$1,050.00	Buy
WEX WEX	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ramsey El-Assal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$136.70 -0.9%	$173.00 ➝ $152.00	Neutral
WFC Wells Fargo & Company	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.56 -0.4%	$97.00 ➝ $102.00	Equal Weight
WGO Winnebago Industries	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.67 +1.0%	$29.00 ➝ $30.00	Neutral
WGS GeneDx	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.12 -1.0%	$70.00 ➝ $74.00	Buy
WRBY Warby Parker	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Ohmes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.02 +2.7%	$33.00	Buy
WS Worthington Steel	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samuel McKinney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.02 -9.2%		Overweight
WSE Wise Group	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.23 +0.3%	$16.10	Equal Weight
WULF TeraWulf	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.58 -1.0%	$36.00	Market Outperform ➝ Buy
WY Weyerhaeuser	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hong Zhang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.65 -2.6%	$30.00 ➝ $31.00	Overweight
WYN Wynnstay Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 365 +4.7%		House Stock
WYN Wynnstay Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 365 +4.7%	GBX 500 ➝ GBX 500	Buy
XOM ExxonMobil	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$136.14 -0.3%	$171.00 ➝ $168.00	Overweight
XYZ Block	Upgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Moley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.81 0.0%		Underweight ➝ Overweight
YMM Full Truck Alliance	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karen Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.07 +4.5%	$8.60 ➝ $10.00	Neutral ➝ Overweight
ZION Zions Bancorporation, N.A.	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.52 +0.5%	$68.00 ➝ $77.00	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:49 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings